...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Translational Study of Alzheimer's Disease (AD) Biomarkers from Brain Tissues in A beta PP/PS1 Mice and Serum of AD Patients
【24h】

Translational Study of Alzheimer's Disease (AD) Biomarkers from Brain Tissues in A beta PP/PS1 Mice and Serum of AD Patients

机译:βPP / PS1小鼠和AD患者血清中脑组织的阿尔茨海默氏病(AD)生物标志物的转化研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to investigate potential biomarkers of Alzheimer's disease (AD). Changes in protein expression in brain tissues from A beta PP/PS1 transgenic mice were evaluated using two-dimensional gel electrophoresis combined with LC-MS/MS. A total of 23 differentially expressed proteins were successfully identified in brain tissues of which 11 were validated by western blot. Then, the levels of these differentially expressed proteins in serum from AD patients and healthy controls were examined. Of these 11 proteins, levels of 5 changed in the same direction in the serum of AD patients as they did in mouse brain: cathepsin B, VDAC1, and cofilin-2 increased, and Alix and ACAP1 decreased. Alix, cofilin-2, and ACAP1 have not been previously associated with AD. More importantly, the serum levels of Alix, cofilin-2, and ACAP1 were significantly different between AD patients and healthy controls. Furthermore, the expressions of cathepsin B, cofilin-2, VDAC1, and ACAP1 strongly correlated with the Mini-Mental State Examination scores of the AD patients. The results indicate that these proteins are putative biomarkers of AD which may be useful in its diagnosis and in the evaluation of new anti-AD drugs both in pre-clinical and clinical studies.
机译:这项研究的目的是调查阿尔茨海默氏病(AD)的潜在生物标志物。使用二维凝胶电泳结合LC-MS / MS评估了A beta PP / PS1转基因小鼠脑组织中蛋白质表达的变化。在脑组织中成功鉴定出总共23种差异表达蛋白,其中11种通过Western blot验证。然后,检查了AD患者和健康对照者血清中这些差异表达蛋白的水平。在这11种蛋白中,AD患者血清中的5种水平的变化与小鼠大脑中的变化方向相同:组织蛋白酶B,VDAC1和cofilin-2升高,而Alix和ACAP1降低。 Alix,cofilin-2和ACAP1之前尚未与AD关联。更重要的是,AD患者和健康对照组之间的Alix,cofilin-2和ACAP1血清水平显着不同。此外,组织蛋白酶B,cofilin-2,VDAC1和ACAP1的表达与AD患者的轻度精神状态检查评分密切相关。结果表明,这些蛋白是AD的推定生物标志物,在其临床前和临床研究中都可用于其诊断和评估新的抗AD药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号